BABYLON PUMP & POWER LIMITED — Capital/Financing Update 2017

Nov 26, 2017

==> picture [26 x 97] intentionally omitted <==

27 November 2017

ASX Release

$4.5million received under Public Offer

The Directors of IM Medical Limited (ASX: IMI, IMIOA) ( IMI or the Company ) are pleased to advise that IMI has received $4.5 million under the Pubic Offer and the Priority Offer pursuant to the Company’s Prospectus dated 24 October 2017. The Company is working with its share registry to process applications and allocate shares and options in conjunction with completing the acquisition of Babylon Operations Pty Ltd (the Acquisition ). Further details of the Acquisition can be found in earlier releases.

The Company held its Annual General Meeting on 1 November 2017 to, among other things, approve the Acquisition. All resolutions put to shareholders were overwhelmingly supported.

The Company has lodged the paperwork to effect the change of the Company’s name to “Babylon Pump & Power Limited”, and when the Company resumes trading on ASX following completion of the Acquisition its ASX code will be changed to “BPP”.

On completion of the Acquisition, Michael Shelby, Patrick Maingard and Michael Kenyon will join the Board, and current directors Nigel Blaze, Richard Wadley and Paul Burton will resign.

The Company is working with ASX to satisfy the requirements of readmission to quotation, with a view to the Company’s shares and listed options resuming trading on ASX in the week commencing 4 December 2017.

Richard Wadley Company Secretary

IM Medical Limited T 03 9607 8280 Level 40 F 03 9607 8285 140 William St. Melbourne VIC 3000 Aust E im.medical@icloud.com ACN 009 436 908 W immedical.com.au